Hoth Therapeutics to Participate in LD Micro's Zooming with LD, August 11th 8 AM PDT
Hoth Therapeutics, Inc. (NASDAQ:HOTH) announced its participation in LD Micro's Zooming with LD on August 11, 2020, at 8 AM PDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Hoth Therapeutics, Inc. (NASDAQ:HOTH) announced its participation in LD Micro's Zooming with LD on August 11, 2020, at 8 AM PDT. CEO Robb Knie will present an overview of the company's operations and recent advancements, particularly the development of a breath-based COVID-19 mobile testing device. This virtual presentation marks an important opportunity for Hoth to showcase its innovations in biopharmaceuticals, especially in treating dermatological disorders and COVID-19 vaccine development. For access, use the password HOTHwithLD.
Details
News Market Reaction – HOTH
The recorded move for HOTH in the trading session of this news was -6.07%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, NY / ACCESSWIRE / August 10, 2020 / Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company, announced today that the Company would be presenting at LD Micro's Zooming with LD on Tuesday, August 11th, 2020.
Robb Knie, Chief Executive Officer, will be presenting an overview of the company, as well as discussing recent developments and key highlights, including the company's just announced license to pursue the development of a breath-based COVID-19 mobile testing device.
The Hoth Therapeutics presentation will take place virtually over Zoom on Tuesday, August 11th, at 8 AM PDT.
To join the presentation, click here.
The password is HOTHwithLD
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure micro-cap index (LDMi) which covers stocks in North America with market capitalizations between
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please visit www.hoththerapeutics.com.
SOURCE: Hoth Therapeutics, Inc.
View source version on accesswire.com:
https://www.accesswire.com/601064/Hoth-Therapeutics-to-Participate-in-LD-Micros-Zooming-with-LD-August-11th-8-AM-PDT
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.